Turn Therapeutics Inc. (TTRX) Institutional Ownership Changes & 13F Activity
Turn Therapeutics Inc. (TTRX). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q3 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Vanguard Capital Management Llc, Blackrock, Inc., Geode Capital Management, Llc, Morgan Stanley, and Millennium Management Llc.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Millennium Management Llc | Buy | +107,251 | +177.1% | 167,802 | $2.41M | Q3 2026 | Nov 16, 2026 |
| Susquehanna International Group, Llp | Buy | +94,076 | — | 94,076 | $1.35M | Q3 2026 | Nov 16, 2026 |
| Northern Trust Corp | Buy | +30,762 | — | 30,762 | $442.67K | Q3 2026 | Nov 16, 2026 |
| Royal Bank Of Canada | Sell | -27,842 | -98.6% | 408 | $6.00K | Q3 2026 | Nov 16, 2026 |
| Goldman Sachs Group Inc | Buy | +27,510 | — | 27,510 | $395.87K | Q3 2026 | Nov 16, 2026 |
| Charles Schwab Investment Management Inc | Buy | +16,310 | — | 16,310 | $234.70K | Q3 2026 | Nov 16, 2026 |
| Exoduspoint Capital Management, Lp | Buy | +12,098 | — | 12,098 | $174.09K | Q3 2026 | Nov 16, 2026 |
| Schonfeld Strategic Advisors Llc | Buy | +11,214 | — | 11,214 | $161.37K | Q3 2026 | Nov 16, 2026 |
| Tower Research Capital Llc (Trc) | Buy | +2,671 | — | 2,671 | $38.44K | Q3 2026 | Nov 16, 2026 |
| Bridgewater Advisors Inc. | Sell | -2,000 | -7.3% | 25,326 | $226.41K | Q3 2026 | Nov 16, 2026 |
| Vanguard Capital Management Llc | Buy | +349,592 | +470.5% | 423,893 | $6.10M | Q3 2026 | Nov 13, 2026 |
| Blackrock, Inc. | Buy | +220,437 | +571.2% | 259,028 | $3.73M | Q3 2026 | Nov 13, 2026 |
| Morgan Stanley | Buy | +128,327 | +1130.9% | 139,674 | $2.01M | Q3 2026 | Nov 13, 2026 |
| Hrt Financial Lp | Buy | +57,450 | — | 57,450 | $826.00 | Q3 2026 | Nov 13, 2026 |
| Vanguard Fiduciary Trust Co | Buy | +23,568 | +188.8% | 36,048 | $518.73K | Q3 2026 | Nov 13, 2026 |
| Jump Financial, Llc | Buy | +14,944 | — | 14,944 | $215.04K | Q3 2026 | Nov 13, 2026 |
| Qube Research & Technologies Ltd | Buy | +10,941 | — | 10,941 | $157.44K | Q3 2026 | Nov 13, 2026 |
| Vanguard Global Advisers, Llc | Buy | +6,383 | — | 6,383 | $91.85K | Q3 2026 | Nov 13, 2026 |
| Aster Capital Management (Difc) Ltd | Buy | +5,235 | — | 5,235 | $75.33K | Q3 2026 | Nov 12, 2026 |
| Hightower Advisors, Llc | Buy | +24,279 | — | 24,279 | $349.38K | Q3 2026 | Nov 10, 2026 |
| Composition Wealth, Llc | Sell | -6,000 | -37.5% | 10,000 | $143.90K | Q3 2026 | Nov 10, 2026 |
| Ubs Group Ag | Buy | +364 | +16.1% | 2,627 | $37.80K | Q3 2026 | Nov 10, 2026 |
| Geode Capital Management, Llc | Buy | +141,489 | +825.4% | 158,631 | $2.28M | Q3 2026 | Nov 06, 2026 |
| Barclays Plc | Buy | +13,748 | — | 13,748 | $197.83K | Q3 2026 | Nov 06, 2026 |
| Lpl Financial Llc | Buy | +5,800 | +56.3% | 16,100 | $231.68K | Q3 2026 | Nov 06, 2026 |
| Citigroup Inc | Buy | +4,723 | — | 4,723 | $67.96K | Q3 2026 | Nov 04, 2026 |
| Caitong International Asset Management Co., Ltd | Sell | -16 | -51.6% | 15 | $216.00 | Q3 2026 | Oct 29, 2026 |
| Parkside Financial Bank & Trust | Buy | +10 | — | 10 | $144.00 | Q3 2026 | Oct 27, 2026 |
| Td Waterhouse Canada Inc. | Buy | +3,059 | — | 3,059 | $40.38K | Q3 2026 | Oct 16, 2026 |
| Steelpeak Wealth, Llc | Buy | +1,819 | +0.7% | 251,275 | $3.62M | Q3 2026 | Oct 16, 2026 |
Frequently asked questions about TTRX activity
Which institutional owners are buying TTRX?
Institutional owners buying TTRX include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in TTRX activity?
"Buy" means an investor increased their reported position in TTRX compared to the prior reporting period. This reflects growing exposure to Turn Therapeutics Inc. (TTRX) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in TTRX increasing?
Institutional interest in TTRX can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related TTRX Institutional Insights
- TTRX Overview
- TTRX 13F Institutional Holders
- TTRX Superinvestors
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- TTRX Insider Trading & SEC Form 4 Activity
- TTRX Articles
- Top Institutional Investor Stock Rankings